Myc Proto-Oncogene Protein (c-Myc) Monoclonal Antibody

• Description:

  Myc Proto-Oncogene Protein (c-Myc) Monoclonal Antibody_x000D_ Catalog number: B2017091_x000D_ Lot number: Batch Dependent_x000D_ Expiration Date: Batch dependent_x000D_ Amount: 50 ug_x000D_ Molecular Weight or Concentration: N/A_x000D_ Supplied as: Solution_x000D_ Applications: a molecular tool for various biochemical applications_x000D_ Storage: -20℃_x000D_ Keywords: c-Myc_x000D_ Grade: Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ References:_x000D_ 1: Molyneux EM, Rochford R, Griffin B, Newton R, Jackson G, Menon G, Harrison CJ, Israels T, Bailey S. Burkitt's lymphoma Lancet. 2012 Mar 31;379(9822):1234-44._x000D_ 2: Pillow TH, Adhikari P, Blake RA, Chen J, Del Rosario G, Deshmukh G, Figueroa I, Gascoigne KE, Kamath AV, Kaufman S, Kleinheinz T, Kozak KR, Latifi B, Leipold DD, Sing Li C, Li R, Mulvihill MM, O'Donohue A, Rowntree RK, Sadowsky JD, Wai J, Wang X, Wu C, Xu Z, Yao H, Yu SF, Zhang D, Zang R, Zhang H, Zhou H, Zhu X, Dragovich PS. Antibody Conjugation of a Chimeric BET Degrader Enables in vivo Activity ChemMedChem. 2020 Jan 7;15(1):17-25._x000D_ 3: Ennishi D, Jiang A, Boyle M, Collinge B, Grande BM, Ben-Neriah S, Rushton C, Tang J, Thomas N, Slack GW, Farinha P, Takata K, Miyata-Takata T, Craig J, Mottok A, Meissner B, Saberi S, Bashashati A, Villa D, Savage KJ, Sehn LH, Kridel R, Mungall AJ, Marra MA, Shah SP, Steidl C, Connors JM, Gascoyne RD, Morin RD, Scott DW. Double-Hit Gene Expression Signature Defines a Distinct Subgroup of Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma J Clin Oncol. 2019 Jan 20;37(3):190-201._x000D_ 4: Daniel CJ, Sun XX, Chen Y, Zhang X, Dai MS, Sears RC. Detection of Post-translational Modifications on MYC Methods Mol Biol. 2021;2318:69-85._x000D_ 5: Evan GI, Lewis GK, Ramsay G, Bishop JM. Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product Mol Cell Biol. 1985 Dec;5(12):3610-6._x000D_ 6: Siegel J, Brandner G, Hess RD. Cross-reactivity of the monoclonal antibody 9E10 with murine c-MYC Int J Oncol. 1998 Dec;13(6):1259-62._x000D_ 7: Royds JA, Sharrard RM, Parsons MA, Lawry J, Rees R, Cottam D, Wagner B, Rennie IG. C-myc oncogene expression in ocular melanomas Graefes Arch Clin Exp Ophthalmol. 1992;230(4):366-71._x000D_ 8: Thieblemont C, Bernard S, Meignan M, Molina T. Optimizing initial therapy in DLBCL Best Pract Res Clin Haematol. 2018 Sep;31(3):199-208._x000D_ 9: Sikora K, Chan S, Evan G, Gabra H, Markham N, Stewart J, Watson J. c-myc oncogene expression in colorectal cancer Cancer. 1987 Apr 1;59(7):1289-95._x000D_ 10: Schüchner S, Behm C, Mudrak I, Ogris E. The Myc tag monoclonal antibody 9E10 displays highly variable epitope recognition dependent on neighboring sequence context Sci Signal. 2020 Jan 28;13(616):eaax9730. _x000D_ _x000D_ Products Related to Myc Proto-Oncogene Protein (c-Myc) Monoclonal Antibody can be found at Antibodies

• Short Description:

  Catalog Number: B2017091 (50 ug)

• Weight:

  0.15

• Length:

  2

• Width:

  0.5

• Height:

  0.5

• Height :

  0.5

• CAS Number:

  9007-83-4